Liquid biopsy refers to the sampling and molecular analysis of the biofluids of circulating
tumor cells, extracellular vesicles, nucleic acids, and so forth. Exosomes are small …

MicroRNAs (miRNAs) are emerging as biomarkers for the detection and prognosis of
cancers due to their inherent stability and resilience. To summarize the evidence regarding …

The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …

Diagnostic methods currently used for bladder cancer are cystoscopy and urine cytology.
Cystoscopy is an invasive tool and has low sensitivity for carcinoma in situ. Urine cytology is …

Extracellular vesicles (EVs) are a heterogeneous collection of membrane-bound structures
that play key roles in intercellular communication. EVs are potent regulators of …

Since the discovery of circulating tumor cells in 1869, technological advances in the study of
biomarkers from liquid biopsy have made it possible to diagnose disease in a less invasive …

Background: Early and accurate diagnosis of ischaemic stroke (IS) requires the use of an
optimized biomarker. Exosomal microRNAs have the potential to serve as biomarkers owing …

Bladder cancer (BCa) is the most prevalent neoplasia of the urinary tract. Unfortunately,
limited improvements in effective BCa management have meant that it remains a …

Almost all clinical oncologists agree that the discovery of reliable, accessible, and non-
invasive biomarkers is necessary to decrease cancer mortality. It is possible to employ …

Extracellular vesicles (EVs) are small membrane vesicles released by all cells and involved
in intercellular communication. Importantly, EVs cargo includes nucleic acids, lipids, and …